首页 > 市场调查报告书 > 医疗设备

体外诊断

安全采血针市场规模、份额及成长分析（依产品类型、应用、最终用户及地区划分）－2026-2033年产业预测

市场调查报告书

商品编码

1897823

安全采血针市场规模、份额及成长分析（依产品类型、应用、最终用户及地区划分）－2026-2033年产业预测

Safety Lancet Market Size, Share, and Growth Analysis, By Product Type (Push Button Safety Lancet, Pressure Activated Safety Lancet), By Application (Blood Glucose Testing, Haemoglobin Testing), By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月25日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，安全采血针市场规模将达到 19.1 亿美元，到 2025 年将达到 20.9 亿美元，到 2033 年将达到 43.1 亿美元，在预测期（2026-2033 年）内，复合年增长率为 9.5%。

安全采血针市场正经历显着扩张，主要驱动因素是糖尿病和感染疾病发病率的上升。采血针正成为医疗保健机构不可或缺的工具，尤其是在血糖值监测和诊断方面。人们对更安全、更便利、更易用的单次使用采血采血针的需求正在飙升。在印度和中国等新兴市场，医疗机构数量的增加和意识提升为采血针生产商带来了巨大的成长机会。然而，挑战依然存在，例如医护人员可能因针刺伤而感染疾病。此外，重复使用采血针的风险也促使医疗机构加强安全措施，并推动一次性产品的更广泛应用。

安全采血针市场驱动因素

受糖尿病日益普遍这项全球性健康挑战的推动，安全采血针市场正经历显着成长。预计这一趋势将持续加速，1型和第2型糖尿病患者人数的不断增加给全球医疗保健系统带来了沉重的经济负担。造成这一趋势的因素包括肥胖、吸烟和缺乏运动等不健康的生活方式，以及日益增长的都市化进程。此外，随着人口老化，糖尿病的发病率预计将进一步上升，从而推动对安全采血针的需求，使其成为应对这一紧迫健康问题的必要解决方案。

安全采血针市场的限制

安全采血针市场的成长受到许多挑战的限制，其中最显着的是许多发展中地区对家用采血针的认知度较低。这种认知差距严重阻碍了那些本可从这些医疗设备中获益匪浅的人群接受和使用家用采血针，以满足其基本的诊断和监测需求。对家用采血针的益处和可及性缺乏了解限制了其普及，并成为该细分市场扩张的一大障碍。解决这些认知问题对于释放安全采血针的潜力、改善医疗服务不足地区的医疗保健至关重要。

安全采血针市场趋势

安全采血针市场正经历显着成长，这主要得益于提升用户安全性和舒适度的创新技术发展。现代安全采血针配备了先进的功能，例如可伸缩装置，可在使用后安全收纳针头，从而显着降低针刺伤的风险。这种从传统基础设计到更先进、更人性化产品的演变，反映了医疗机构对病人安全和感染控制日益增长的重视。此外，糖尿病盛行率的上升以及对血糖自我监测系统需求的增加，进一步推动了市场动态，促使消费者寻求更安全、更有效率的采血解决方案。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较

主要企业简介

Cardinal Health（United States）
Greiner Bio-One International GmbH（Austria）
Sarstedt AG & Co. KG（Germany）
Nipro Corporation（Japan）
Improve Medical Technology Co. Ltd.（China）
Simple Diagnostics（United States）
Ypsomed AG（Switzerland）
Owen Mumford Ltd.（United Kingdom）
Arkray Inc.（Japan）
Perrigo Company plc（Ireland）
Smiths Medical（United States）
Medline Industries, Inc.（United States）
Omron Healthcare, Inc.（Japan）
F. Hoffmann-La Roche AG（Switzerland）
Trinity Biotech（Ireland）
Microdot Healthcare（United Kingdom）
MED TRUST Holding Co.（Austria）
Nemaura Medical Inc.（United Kingdom）

结论与建议

简介目录

Product Code: SQMIG35A2818

Safety Lancet Market size was valued at USD 1.91 Billion in 2024 and is poised to grow from USD 2.09 Billion in 2025 to USD 4.31 Billion by 2033, growing at a CAGR of 9.5% during the forecast period (2026-2033).

The safety lancet market is experiencing significant expansion, largely fueled by the rising incidence of diabetes and infectious diseases. Lancets are increasingly essential in healthcare, particularly for blood glucose monitoring and diagnostics. Demand is soaring for user-friendly, single-use lancets that enhance safety and convenience. Emerging markets like India and China offer substantial growth prospects for lancet manufacturers, driven by an increase in healthcare facilities and heightened public awareness of health issues. However, challenges persist, notably concerns over needlestick injuries that threaten healthcare workers through potential infectious disease transmission. Additionally, the risks associated with reusing lancets underscore the shift towards adopting single-use options more broadly within healthcare settings, promoting safer practices.

Top-down and bottom-up approaches were used to estimate and validate the size of the Safety Lancet market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Safety Lancet Market Segments Analysis

Global Safety Lancet Market is segmented by Product Type, Application, End User and region. Based on Product Type, the market is segmented into Push Button Safety Lancet, Pressure Activated Safety Lancet and Side Button Safety Lancet. Based on Application, the market is segmented into Blood Glucose Testing, Haemoglobin Testing, Cholesterol Testing and Coagulation Testing. Based on End User, the market is segmented into Hospitals and Clinics, Diagnostic Centers and Pathology Laboratories, Home Diagnostics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Safety Lancet Market

The Safety Lancet market is experiencing remarkable growth, driven by the increasing prevalence of diabetes, a significant global health challenge that is expected to escalate over time. This rise in diabetes cases, encompassing both type 1 and type 2 variants, represents a considerable financial strain on healthcare systems across the globe. Factors contributing to this trend include unhealthy lifestyle choices such as obesity, smoking, lack of physical activity, and the ongoing trend of urbanization. Additionally, as the population ages, the incidence of diabetes is likely to rise, leading to a greater demand for safety lancets as a necessary solution to manage this pressing health issue.

Restraints in the Safety Lancet Market

The growth of the safety lancet market is hindered by several challenges, particularly the limited awareness surrounding homecare lancets in many developing regions. This gap in understanding significantly impedes the acceptance and utilization of these medical devices among individuals who could greatly benefit from them for essential diagnostic and monitoring needs. The insufficient knowledge about the advantages and availability of homecare lancets restricts their adoption, thereby posing a notable hurdle to the expansion of this market segment. Addressing these awareness issues is critical for unlocking the potential of safety lancets and improving healthcare accessibility in underserved areas.

Market Trends of the Safety Lancet Market

The safety lancet market is witnessing remarkable expansion, fueled by innovative technological developments that enhance user safety and comfort. Modern safety lancets now incorporate advanced features such as retractable mechanisms, which significantly reduce the risk of needlestick injuries by ensuring needles are safely contained after use. This evolution from traditional, basic designs to more advanced, user-friendly options reflects a growing emphasis on patient safety and infection control within healthcare settings. Additionally, the rising prevalence of diabetes and the demand for self-monitoring blood glucose systems further propel market dynamics, as consumers increasingly seek safer and more efficient blood collection solutions.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Safety Lancet Market Size by Product Type & CAGR (2026-2033)

Market Overview
Push Button Safety Lancet
Pressure Activated Safety Lancet
Side Button Safety Lancet

Global Safety Lancet Market Size by Application & CAGR (2026-2033)

Market Overview
Blood Glucose Testing
Haemoglobin Testing
Cholesterol Testing
Coagulation Testing

Global Safety Lancet Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals and Clinics
Diagnostic Centers and Pathology Laboratories
Home Diagnostics
Others

Global Safety Lancet Market Size & CAGR (2026-2033)

North America (Product Type, Application, End User)
- US
- Canada
Europe (Product Type, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Cardinal Health (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Greiner Bio-One International GmbH (Austria)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sarstedt AG & Co. KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nipro Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Improve Medical Technology Co. Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Simple Diagnostics (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ypsomed AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Owen Mumford Ltd. (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Arkray Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Perrigo Company plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Smiths Medical (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medline Industries, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Omron Healthcare, Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Trinity Biotech (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Microdot Healthcare (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MED TRUST Holding Co. (Austria)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nemaura Medical Inc. (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments